Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contacts | Login 
  Users Online: 267 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
 Back To Article

  Reader Comments

Year : 2021 | Volume:  11 | Issue Number:  1


Firibastat, the first-in-class brain aminopeptidase a inhibitor, in the management of hypertension: A review of clinical trials

Alomar Sara Abdulrahman, Alghabban Sarah Ali, Alharbi Hadeel Abdulaziz, Almoqati Mehad Fahad, Alduraibi Yazid, Abu-Zaid Ahmed

Add Your Comments
No one has added comments on this article. Click here to add your remarks